Michael C. Sweeney

Michael Sweeney is counsel in the Technology Transactions and Licensing Group. He advises life science companies, investors and other financial institutions on complex corporate transactional matters, with a specific focus on the biopharmaceutical industry. Mr. Sweeney represents clients in drafting and negotiating commercial agreements, including license, research and collaboration, manufacturing, co-commercialization and co-promotion, royalty purchase and sale, services, distribution, clinical trial and supply agreements. He also assists with intellectual property due diligence for mergers and acquisitions and private and public financings, including IPOs and follow-on offerings.